Hu H, Wang X, Liu S. Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence: Case report and literature review.
Medicine (Baltimore) 2016;
95:e4799. [PMID:
27603389 PMCID:
PMC5023912 DOI:
10.1097/md.0000000000004799]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND
Thalidomide has been successful use in patients with refractory Crohn disease (CD) in recent years.
METHODS
We collected the data of a postoperative CD patient who was prescribed thalidomide to induce remission and reviewed the relevant literatures.
RESULTS
A 51-year-old female was diagnosed as CD after an urgent terminal intestinal resection and presented endoscopic recurrence despite the prophylactic treatment with azathioprine (AZA). Fortunately, she achieved mucosal healing (MH) at a low dose of thalidomide for 15 months.
CONCLUSION
Thalidomide is effective to induce MH in the postoperative CD endoscopic recurrence.
Collapse